Ning Shen
6Patents
2h-index
24Co-inventors
43Inventor score
Filing activity: Jun 8, 2012 → Jan 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10537560B2 | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | Chemistry; Metallurgy | 4 | Active |
| US10342786B2 | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | Chemistry; Metallurgy | 4 | Active |
| US9453062B2 | Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof | Human Necessities | 2 | Active |
| US11479770B2 | Use of p38 inhibitors to reduce expression of DUX4 | Physics | 0 | Active |
| US11465984B2 | Compound having ERK kinase inhibitory activity and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11291659B2 | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.